candida antigen
Vaccineexperimental
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
1
Earliest trial started Jul 1, 2017 (NCT04399577)
Timeline
Indications
Approved for
Mechanism of action
- CandidaImmunity, active
Candida immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06749665 | N/A | Dec 20, 2024 | Sohag University |
| NCT06564805 | N/A | Aug 20, 2024 | Universidad Autonoma de Nuevo Leon |
| NCT05291845 | Phase 2 | Apr 3, 2022 | Zagazig University |
| NCT05652998 | Phase 4 | Oct 15, 2021 | Sohag University, South Valley University |
| NCT03853785 | Phase 3 | Feb 29, 2020 | Assiut University |
| NCT04399577 | Phase 2 | Jul 1, 2017 | Zagazig University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sohag University | Academic/Hospital | 2 | 1 | 2 | 2021 |
| Zagazig University | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Assiut University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| South Valley University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Universidad Autonoma de Nuevo Leon | Academic/Hospital | 1 | 1 | 1 | 2024 |
5 organizations
Page 1 / 1